Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR

Beta Bionics, Inc.

Irvine, CA, US

BETA BIONICS, INC. appears in FDA device records in Irvine, CA. FDA records list 6 510(k) clearances between and , no PMA records and one registered establishment. As of , FDA records show 3 recalls for this company, and at least one establishment registration is current.

FDA records held for this company

510(k) clearances
6
PMA records
0
Recall records
3
Registered establishments
1

510(k) clearance history

FDA records hold 6 510(k) clearances for Beta Bionics, Inc. between 2023 and 2026. The busiest year on record is 2023, with 4. The most recent is 2026, with 1.

Clearances by year, as a table
510(k) clearance decisions for Beta Bionics, Inc., by decision year
YearClearances
20234
20251
20261
510(k) clearances on record, most recent first
K numberDeviceProduct codeDecisionDecision date
K253976iLet ACE PumpQFGSubstantially Equivalent
K252770iLet ACE PumpQFGSubstantially Equivalent
K232224iLet® Dosing Decision SoftwareQJISubstantially Equivalent
K231485iLet® ACE PumpQFGSubstantially Equivalent
K223846iLet® ACE PumpQFGSubstantially Equivalent
K220916iLet® Dosing Decision SoftwareQJISubstantially Equivalent

Registered establishments

FDA registered establishments for Beta Bionics, Inc., with the product codes listed at each
RegistrationFEIEstablishmentAddressRegistration expiresProduct codes listed
30190040873019004087BETA BIONICS, INC.11 Hughes, Irvine, CA 92618 US2026

Registration numbers link to the FDA registration and listing record for that establishment.

FDA product codes

Recall records

Device recall records naming this company, most recent first
RecallProductReasonClassificationInitiatedStatus
Z-1996-2026iLet Bionic Pancreas, REF: BB1001insulin pump software versions 1.4.2, and 1.4.3 issue with Dexcom Continuous Glucose Monitoring (CGM) G7 sensor may result in delayed CGM reading then switch to non-CGM dosing, leading to only basal/requested meal doses provided, no correction doses/insulin reductions/suspensions for high/low glucose unless blood glucose entered for sensor life or replacement. Potential health risks to users include severe hyperglycemia with and without DKA and severe hypoglycemia.Class IIOpen, Classified
Z-2513-2026iLet Bionic Pancreas, REF: BB1001The reason for the recall is: it was found in version 3.3.6 of the iLet ACE Pump firmware and all previous releases that a screen unlock failure could occur when the user successfully slides the unlock slider on the Lock Screen, no screen transition occurs, and the user remains on the Lock Screen. Because the user cannot exit the Lock Screen, the user is unable to perform a cartridge change or meal announcement. If this occurs and therapy is in progress, therapy will continue normally until the insulin cartridge is depleted. The user will be unable to perform a cartridge change or a meal announcement and will be stuck on the screen until the battery fully drains. This can lead to hyperglycemia.Class IIOpen, Classified
Z-1809-2026iLet Ace Pump Kit REF: BB1001 iLet Dosing Decision Softwareit was found that in versions 1.3.7, 1.4.2, and 1.4.3, the Lock Screen and Limited Access Passcode Screen on the iLet graphical user interface (GUI) include certain icons displayed in the status bar that are active, thereby allowing the user to bypass those screens when those icons on the status bar are pressed, allowing unauthorized access while the device is in Limited Access Mode. A Health Risk associated with Limited access mode includes severe hypoglycemia due to unauthorized access to the iLet if someone were to make unauthorized meal announcements or stopped insulin delivery.Class IIOpen, Classified

Verification record

There is no verification record for this company. Most companies on this site have none: a record exists only where a company asked to be verified and MDM ran the checks, so the absence of one says nothing about the company.

Where there is a record, this is where it appears: what was checked, when it was checked, and the current status. An MDM Verified badge on another website links to a verify address on this domain that resolves to this section. A badge that does not resolve here is not ours.

What MDM checks, and what it does not

MDM coverage

MDM coverage of this company lists here, newest first. Submit news.

Is this your company?

This page is built from public FDA records. Company pages are free and factual, and stay free whether or not anyone claims them. Membership never changes editorial coverage or vetting outcomes.

Claiming lets Beta Bionics, Inc. edit what it says about itself and list the categories it works in. It grants no badge: claiming is not verification.

Claim this page

Data as of , FDA export datePage updated Source: openFDA, public domain